Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus.
Journal: Annals of the rheumatic diseases
Published: May 27, 2022
Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus.
Journal: Annals of the rheumatic diseases
Published: May 13, 2022
Identification and Contribution of Inflammation-Induced Novel MicroRNA in the Pathogenesis of Systemic Lupus Erythematosus.
Journal: Frontiers in immunology
Published: January 04, 2022
Efficacy and Safety of Ustekinumab in Patients With Active Systemic Lupus Erythematosus: Results of a Phase II Open-label Extension Study.
Journal: The Journal of rheumatology
Published: November 19, 2021
Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus.
Journal: Lupus science & medicine
Published: August 23, 2021
CD8+ T regulatory cells in lupus.
Journal: Rheumatology and immunology research
Published: August 10, 2021
Interferon Genes Are Influenced by 17β-Estradiol in SLE.
Journal: Frontiers in immunology
Published: June 15, 2021
Effects of Peptide-Induced Immune Tolerance on Murine Lupus.
Journal: Frontiers in immunology
Published: February 01, 2021
A Panel of Biomarkers Associates With Increased Risk for Cardiovascular Events in Women With Systemic Lupus Erythematosus.
Journal: ACR open rheumatology
Published: December 16, 2020
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance.
Journal: Annals of the rheumatic diseases
Published: October 22, 2020
Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: April 22, 2020
Last Updated: 09/26/2026